These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 15918557

  • 1. [Pathologic characteristics and evaluation of the pancreatic cancer].
    Fukushima N, Mukai K.
    Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557
    [Abstract] [Full Text] [Related]

  • 2. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV, Basturk O, Cheng JD, Andea AA.
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [Abstract] [Full Text] [Related]

  • 3. Current understanding of precursors to pancreatic cancer.
    Takaori K.
    J Hepatobiliary Pancreat Surg; 2007 Oct; 14(3):217-23. PubMed ID: 17520195
    [Abstract] [Full Text] [Related]

  • 4. Current topics on precursors to pancreatic cancer.
    Takaori K, Hruban RH, Maitra A, Tanigawa N.
    Adv Med Sci; 2006 Oct; 51():23-30. PubMed ID: 17357272
    [Abstract] [Full Text] [Related]

  • 5. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
    Katabi N, Klimstra DS.
    J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
    Adsay NV, Longnecker DS, Klimstra DS.
    Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
    [Abstract] [Full Text] [Related]

  • 7. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
    Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE, Hruban RH.
    Cancer Res; 2000 Apr 01; 60(7):2002-6. PubMed ID: 10766191
    [Abstract] [Full Text] [Related]

  • 8. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.
    Recavarren C, Labow DM, Liang J, Zhang L, Wong M, Zhu H, Wang J, Francis F, Xu R.
    Hum Pathol; 2011 Jan 01; 42(1):18-24. PubMed ID: 21056895
    [Abstract] [Full Text] [Related]

  • 9. Mucin expression profile in pancreatic cancer and the precursor lesions.
    Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, Yonezawa S.
    J Hepatobiliary Pancreat Surg; 2007 Jan 01; 14(3):243-54. PubMed ID: 17520199
    [Abstract] [Full Text] [Related]

  • 10. [Clinicopathological aspects of pancreatic cancer].
    Egawa S, Sunamura M, Abe H, Motoi F, Fukuyama S, Matsuno S.
    Gan To Kagaku Ryoho; 2005 May 01; 32(5):605-11. PubMed ID: 15918558
    [Abstract] [Full Text] [Related]

  • 11. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.
    Hepatogastroenterology; 2005 May 01; 52(62):398-403. PubMed ID: 15816444
    [Abstract] [Full Text] [Related]

  • 12. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
    Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.
    Am J Surg Pathol; 2006 Dec 01; 30(12):1561-9. PubMed ID: 17122512
    [Abstract] [Full Text] [Related]

  • 13. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N, Ohmuraya M, Ida S, Hashimoto D, Ikuta Y, Chikamoto A, Hirota M, Baba H.
    J Hepatobiliary Pancreat Sci; 2013 Aug 01; 20(6):620-7. PubMed ID: 23475261
    [Abstract] [Full Text] [Related]

  • 14. The use of fine needle aspiration cytology for the distinction of pancreatic mucinous neoplasia.
    Stelow EB, Shami VM, Abbott TE, Kahaleh M, Adams RB, Bauer TW, Debol SM, Abraham JM, Mallery S, Policarpio-Nicolas ML.
    Am J Clin Pathol; 2008 Jan 01; 129(1):67-74. PubMed ID: 18089490
    [Abstract] [Full Text] [Related]

  • 15. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.
    Oncol Rep; 2003 Jan 01; 10(1):21-5. PubMed ID: 12469138
    [Abstract] [Full Text] [Related]

  • 16. Precursor lesions in pancreatic cancer: morphological and molecular pathology.
    Scarlett CJ, Salisbury EL, Biankin AV, Kench J.
    Pathology; 2011 Apr 01; 43(3):183-200. PubMed ID: 21436628
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T.
    J Hepatobiliary Pancreat Surg; 2007 Apr 01; 14(3):233-7. PubMed ID: 17520197
    [Abstract] [Full Text] [Related]

  • 18. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
    Riall TS, Stager VM, Nealon WH, Townsend CM, Kuo YF, Goodwin JS, Freeman JL.
    J Am Coll Surg; 2007 May 01; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
    [Abstract] [Full Text] [Related]

  • 19. [Precursors to pancreatic cancer].
    Søreide K, Immervoll H, Molven A.
    Tidsskr Nor Laegeforen; 2006 Mar 23; 126(7):905-8. PubMed ID: 16554881
    [Abstract] [Full Text] [Related]

  • 20. Pancreatic intraepithelial neoplasia revisited and updated.
    Sipos B, Frank S, Gress T, Hahn S, Klöppel G.
    Pancreatology; 2009 Mar 23; 9(1-2):45-54. PubMed ID: 19077454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.